Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort studyDaniel K. Nomah, Bibiana Morell, Ingrid Vilaró et al.|The Lancet HIV|2021Cited by 110
Strategies to reengage patients lost to follow up in HIV care in high income countries, a scoping reviewJorge Palacio‐Vieira, Eva González‐Roca, Juliana Reyes‐Urueña et al.|BMC Public Health|2021Cited by 37
Early lipid changes with atazanavir/ritonavir or darunavir/ritonavirE Martinez, Ana Gonzalez‐Cordón, Elena Ferrer et al.|HIV Medicine|2014Cited by 32
Renal Safety of Tenofovir Disoproxil Fumarate in HIV-1 Treatment-experienced Patients with Adverse Events Related to Prior NRTI UseSantiago Moreno, María Luisa Álvarez, Peré Domingo et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2006Cited by 30
Differential Body Composition Effects of Protease Inhibitors Recommended for Initial Treatment of HIV Infection: A Randomized Clinical TrialEstebán Martínez, Sergio Padilla, Elena Ferrer et al.|Clinical Infectious Diseases|2014Cited by 29